(Euronext BTLS), an innovative Agricultural Technology (AgTech) company, has announced a significant milestone with the patent grants for its first biofungicide, EVOCA™, from both the European Patent Office (EPO) and the United States Patent and Trademark Office (USPTO). This achievement underscores Biotalys’s commitment to developing sustainable crop protection solutions through protein-based biocontrols.

Confirmation of Innovation

Kevin Helash, Chief Executive Officer of Biotalys, expressed enthusiasm over the recent patent grants: “We are very pleased with the recent decisions from the European and U.S. patent offices, which confirm the truly innovative nature of our solution. This exclusivity supports our commercial partners in producing or distributing EVOCA across Europe and the United States, ultimately benefiting fruit and vegetable growers facing challenges from fungal diseases.”

In addition to these grants, Biotalys is actively seeking patent protection for EVOCA’s active ingredient in key global markets, including Argentina, Brazil, and South Africa, which are vital for crop protection. The company has already secured various patents worldwide for different elements of its technology and is committed to strengthening its intellectual property portfolio.

A Novel Solution for Crop Protection

EVOCA represents a groundbreaking protein-based biofungicide, having received an entirely new resistance classification by the Fungicide Resistance Action Committee (FRAC). Designed to combat fungal diseases in fruits and vegetables, EVOCA has shown strong performance in trials across diverse regions, climates, soil types, and crops. The product is currently undergoing regulatory review by the U.S. Environmental Protection Agency (EPA) and the Dutch College voor Toelating van Gewasbeschermingsmiddelen en Biociden (CTGB) in the European Union.

The successful launch of EVOCA will set the stage for the anticipated EVOCA NG, which is expected to be Biotalys’s first commercial fungicide derived from its AGROBODY™ technology platform. Both EVOCA and EVOCA NG share the same active ingredient, now protected by the recent patent grants.

Looking Ahead

With these patents in place, Biotalys is well-positioned to lead the charge in sustainable agricultural practices, providing growers with effective solutions to combat fungal threats. As the company continues to advance its AGROBODY™ technology, the future of crop protection looks promising, with innovative products that prioritize sustainability and efficacy. Keep an eye on Biotalys as they pave the way for a new era in agricultural biotechnology.

Source – Biotalys